EA016053B1 - Применение молекулы нуклеиновой кислоты, содержащей двухцепочечную область, для лечения пролиферативного нарушения - Google Patents

Применение молекулы нуклеиновой кислоты, содержащей двухцепочечную область, для лечения пролиферативного нарушения Download PDF

Info

Publication number
EA016053B1
EA016053B1 EA200900989A EA200900989A EA016053B1 EA 016053 B1 EA016053 B1 EA 016053B1 EA 200900989 A EA200900989 A EA 200900989A EA 200900989 A EA200900989 A EA 200900989A EA 016053 B1 EA016053 B1 EA 016053B1
Authority
EA
Eurasian Patent Office
Prior art keywords
molecule
molecules
dna
use according
nucleic acid
Prior art date
Application number
EA200900989A
Other languages
English (en)
Russian (ru)
Other versions
EA200900989A1 (ru
Inventor
Мари Дютри
Original Assignee
Сантр Насьональ Де Ля Решерш Сьентифик
Энститю Кюри
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сантр Насьональ Де Ля Решерш Сьентифик, Энститю Кюри filed Critical Сантр Насьональ Де Ля Решерш Сьентифик
Publication of EA200900989A1 publication Critical patent/EA200900989A1/ru
Publication of EA016053B1 publication Critical patent/EA016053B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/312—Phosphonates
    • C12N2310/3125—Methylphosphonates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EA200900989A 2007-01-12 2008-01-11 Применение молекулы нуклеиновой кислоты, содержащей двухцепочечную область, для лечения пролиферативного нарушения EA016053B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07300728A EP1944369A1 (en) 2007-01-12 2007-01-12 Dbait and its standalone uses thereof
PCT/EP2008/050265 WO2008084087A2 (en) 2007-01-12 2008-01-11 Dbait and its standalone uses thereof

Publications (2)

Publication Number Publication Date
EA200900989A1 EA200900989A1 (ru) 2009-12-30
EA016053B1 true EA016053B1 (ru) 2012-01-30

Family

ID=38515555

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200900989A EA016053B1 (ru) 2007-01-12 2008-01-11 Применение молекулы нуклеиновой кислоты, содержащей двухцепочечную область, для лечения пролиферативного нарушения

Country Status (8)

Country Link
US (1) US8093366B2 (ja)
EP (2) EP1944369A1 (ja)
JP (1) JP5462632B2 (ja)
CN (1) CN101622351B (ja)
AU (1) AU2008204486C1 (ja)
CA (1) CA2673972C (ja)
EA (1) EA016053B1 (ja)
WO (1) WO2008084087A2 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015202211B2 (en) * 2010-06-22 2016-09-01 Centre National De La Recherche Scientifique Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates
PT3135301T (pt) 2010-06-22 2018-07-16 Inst Curie Sistema de administração otimizado in vivo com agentes endossomolíticos para conjugados de ácidos nucleicos
EP2527440A1 (en) 2011-05-27 2012-11-28 Institut Curie Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
WO2017013237A1 (en) 2015-07-23 2017-01-26 Institut Curie Use of a combination of dbait molecule and parp inhibitors to treat cancer
CN109069528B (zh) * 2016-03-01 2021-11-05 欧恩科斯欧公司 DBait分子在制备用于治疗三阴性乳腺癌的药物中的用途
WO2017186882A1 (en) * 2016-04-29 2017-11-02 Onxeo A method of predicting a response to an anti-tumor treatment by means of signal interfering dna molecules
WO2018162439A1 (en) 2017-03-08 2018-09-13 Onxeo New predictive biomarker for the sensitivity to a treatment of cancer with a dbait molecule
EP3638252A4 (en) * 2017-06-12 2021-03-10 University of Miami STING-DEPENDENT ACTIVATORS FOR THE TREATMENT OF A DISEASE
CN107793468A (zh) * 2017-06-26 2018-03-13 上海悦良生物科技有限公司 一种检测dna损伤的方法
EP3461488A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dbait molecule and a hdac inhibitor for treating cancer
JP2021515580A (ja) * 2018-03-13 2021-06-24 オンクセオＯｎｘｅｏ がんの治療における獲得耐性に対抗するｄｂａｉｔ分子
CN109321585B (zh) * 2018-09-30 2021-08-06 山东大学 一种利用t4脱氧核糖核酸连接酶提高原核微生物诱变育种效率的方法
MX2021007271A (es) 2018-12-21 2021-07-15 Onxeo Nuevas moleculas de acido nucleico conjugado y sus usos.
BR112021018168B1 (pt) 2019-03-21 2023-11-28 Onxeo Composição farmacêutica, combinação e kit compreendendo uma molécula dbait e um inibidor de quinase para o tratamento de câncer
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
US20230095192A1 (en) * 2020-03-03 2023-03-30 University Of Washington Synthetic agonists of dna-pk and their use
US11897888B1 (en) 2020-04-30 2024-02-13 Stinginn Llc Small molecular inhibitors of sting signaling compositions and methods of use
TW202210633A (zh) 2020-06-05 2022-03-16 法商昂席歐公司 用於治療癌症之dbait分子與kras抑制劑的組合
AR122644A1 (es) 2020-06-19 2022-09-28 Onxeo Nuevas moléculas de ácido nucleico conjugado y sus usos
AU2022409713A1 (en) 2021-12-16 2024-06-20 Valerio Therapeutics New conjugated nucleic acid molecules and their uses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005040378A1 (en) * 2003-10-24 2005-05-06 Institut Curie Nucleic acids useful for triggering tumor cell lethality

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005247807A (ja) * 2004-03-08 2005-09-15 Japan Science & Technology Agency Ｎｓａｉｄを利用した癌治療用組成物
US20060276423A1 (en) * 2005-04-18 2006-12-07 Rachel Altura Survivin-directed RNA interference-compositions and methods

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005040378A1 (en) * 2003-10-24 2005-05-06 Institut Curie Nucleic acids useful for triggering tumor cell lethality

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LI Z. ET AL.: "Targeting Ku protein for sensitizing of breast cancer cells to DNA damage" INTERNATIONAL JOURNAL OF MEDICINE, vol. 14, no. 2, August 2004 (2004-08), pages 153-159, XP008084143 the whole document *
YOO S. AND DYNAN W.S.: "Characterization of the RNA binding properties of Ku protein" BIOCHEMISTRY, vol. 37, 1998, pages 1336-1343, XP002452541 cited in the application the whole document *

Also Published As

Publication number Publication date
US20100022622A1 (en) 2010-01-28
AU2008204486C1 (en) 2013-05-16
CN101622351A (zh) 2010-01-06
EP1944369A9 (en) 2008-10-15
EP2102343B1 (en) 2015-07-08
AU2008204486A1 (en) 2008-07-17
WO2008084087A2 (en) 2008-07-17
AU2008204486B2 (en) 2012-11-29
EP2102343A2 (en) 2009-09-23
CN101622351B (zh) 2014-05-14
US8093366B2 (en) 2012-01-10
EA200900989A1 (ru) 2009-12-30
EP1944369A1 (en) 2008-07-16
JP2010515707A (ja) 2010-05-13
CA2673972A1 (en) 2008-07-17
CA2673972C (en) 2016-03-22
JP5462632B2 (ja) 2014-04-02
WO2008084087A3 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
EA016053B1 (ru) Применение молекулы нуклеиновой кислоты, содержащей двухцепочечную область, для лечения пролиферативного нарушения
JP5662822B2 (ja) 腫瘍細胞致死性をトリガーするのに有用な核酸
JP5415952B2 (ja) Ｄｂａｉｔおよびその使用
KR102441432B1 (ko) Ｄｂａｉｔ 분자의 전신 투여에 의한 암 치료법
Tao et al. Antitumor efficacy of a recombinant EGFR-targeted fusion protein conjugate that induces telomere shortening and telomerase downregulation

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM